Published in Int J Clin Exp Pathol on November 15, 2013
Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis. Ann Transl Med (2015) 0.86
Tight Junctions and the Tumor Microenvironment. Curr Pathobiol Rep (2016) 0.78
Epidermal tight junctions in health and disease. Tissue Barriers (2015) 0.78
Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol (2002) 5.51
Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci (2003) 3.79
Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol (2000) 2.28
The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem J (2006) 2.03
A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest (2007) 1.93
Predicted expansion of the claudin multigene family. FEBS Lett (2011) 1.91
Tight junctions and human diseases. Med Electron Microsc (2003) 1.87
Tight junctions. J Cell Sci (1998) 1.86
Tight junctions and the regulation of gene expression. Biochim Biophys Acta (2008) 1.83
Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol (2010) 1.77
Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest (2008) 1.64
CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol (2008) 1.62
Epithelial tight junctions, gene expression and nucleo-junctional interplay. J Cell Sci (2007) 1.46
Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology (2005) 1.43
Claudin family of proteins and cancer: an overview. J Oncol (2010) 1.42
Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines. Oncogene (2008) 1.40
Polarity proteins regulate mammalian cell-cell junctions and cancer pathogenesis. Curr Opin Cell Biol (2009) 1.28
Regulation and roles for claudin-family tight junction proteins. IUBMB Life (2009) 1.26
The renal segmental distribution of claudins changes with development. Kidney Int (2002) 1.25
Loss of claudin-15, but not claudin-2, causes Na+ deficiency and glucose malabsorption in mouse small intestine. Gastroenterology (2010) 1.20
Claudin-1 is a p63 target gene with a crucial role in epithelial development. PLoS One (2008) 1.20
Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta (2011) 1.16
Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics. Am J Surg Pathol (2002) 1.15
Tight junction-related structures in the absence of a lumen: occludin, claudins and tight junction plaque proteins in densely packed cell formations of stratified epithelia and squamous cell carcinomas. Eur J Cell Biol (2003) 1.13
p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol (2006) 1.13
Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am J Pathol (2005) 1.11
Pathology and pathobiology of actinic (solar) keratosis - an update. Br J Dermatol (2007) 1.11
Claudin-16 and claudin-19 function in the thick ascending limb. Curr Opin Nephrol Hypertens (2010) 1.09
PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int J Med Sci (2009) 1.08
Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol (2005) 1.06
Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res (1992) 1.03
Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum Pathol (2008) 1.03
The heat-shock protein Apg-2 binds to the tight junction protein ZO-1 and regulates transcriptional activity of ZONAB. Mol Biol Cell (2006) 1.00
The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer (2011) 0.96
Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol Biomarkers Prev (2006) 0.95
Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Appl Immunohistochem Mol Morphol (2006) 0.94
Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Cancer Prev Res (Phila) (2008) 0.93
Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis. BMC Cancer (2007) 0.92
Upregulated claudin-1 expression confers resistance to cell death of nasopharyngeal carcinoma cells. Int J Cancer (2010) 0.90
Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor. Cancer Lett (2002) 0.88
Expression of Cdx2 and claudin-2 in the multistage tissue of gastric carcinogenesis. Oncology (2008) 0.88
Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9. Breast Cancer Res (2008) 0.87
The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas. Dermatol Surg (2004) 0.87
Identification of differentially expressed genes in psoriasis using expression profiling approaches. Exp Dermatol (2005) 0.86
Evaluation of drug and sunscreen permeation via skin irradiated with UVA and UVB: comparisons of normal skin and chronologically aged skin. J Dermatol Sci (2012) 0.84
Aberrant expression of tight junction-related proteins ZO-1, claudin-1 and occludin in synovial sarcoma: an immunohistochemical study with ultrastructural correlation. Mod Pathol (2004) 0.83
Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior. APMIS (2007) 0.82
Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma. Anticancer Res (2009) 0.82
Altered expression of claudin-1, claudin-7, and tricellulin regardless of human papilloma virus infection in human tonsillar squamous cell carcinoma. Acta Otolaryngol (2011) 0.80
The targeted overexpression of a Claudin mutant in the epidermis of transgenic mice elicits striking epidermal and hair follicle abnormalities. Mol Biotechnol (2007) 0.79
Tight junctions: is there a role in dermatology? Arch Dermatol Res (2010) 0.78
Claudin-5 haploinsufficiency exacerbates UVB-induced oedema formation by inducing lymphatic vessel leakage. Exp Dermatol (2012) 0.77
A recurrent mutation in PALB2 in Finnish cancer families. Nature (2007) 4.64
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Divergence of tight and adherens junction factors in alveolar epithelium in pulmonary fibrosis. Hum Pathol (2012) 2.13
Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heart. Circ Res (2006) 1.92
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers' lung. Am J Respir Crit Care Med (2002) 1.64
Peroxiredoxins in breast carcinoma. Clin Cancer Res (2003) 1.59
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Laminin-5 gamma2 chain in cryptogenic organizing pneumonia and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2003) 1.49
Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS (2007) 1.41
Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res (2006) 1.36
Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol (2010) 1.19
Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo. Hum Pathol (2004) 1.19
Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer (2004) 1.19
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells. PLoS One (2013) 1.16
Sialometaplasia of the soft palate in a 2-year-old girl. J Can Dent Assoc (2007) 1.12
DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma. Int J Gynecol Cancer (2009) 1.10
Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II). Oral Oncol (2010) 1.09
Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med (2003) 1.08
Claudin-1, -2, -3, -4, -5, and -7 in usual interstitial pneumonia and sarcoidosis. J Histochem Cytochem (2008) 1.08
17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer. Cancer Res (2004) 1.07
Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer. Int J Cancer (2012) 1.07
Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck (2013) 1.07
Thrombospondin-4 expression is rapidly upregulated by cardiac overload. Biochem Biophys Res Commun (2008) 1.06
Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun (2011) 1.06
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer. Breast Cancer Res (2013) 1.06
Tenascin-C is highly expressed in respiratory distress syndrome and bronchopulmonary dysplasia. J Histochem Cytochem (2002) 1.06
8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma. Int J Clin Exp Pathol (2011) 1.03
Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum Pathol (2008) 1.03
Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett (2004) 1.02
Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis. Circulation (2007) 1.02
Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype. Breast Cancer Res Treat (2013) 1.02
Differential expression of superoxide dismutases in lung cancer. Am J Clin Pathol (2004) 1.01
Epigenetic regulation of miR-212 expression in lung cancer. PLoS One (2011) 1.01
Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung. Am J Clin Pathol (2002) 1.01
Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer. Cancer Res (2012) 0.99
Evaluation of neuroendocrine markers in renal cell carcinoma. Diagn Pathol (2010) 0.99
Expression of antioxidant enzymes in astrocytic brain tumors. Brain Pathol (2003) 0.99
p38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms. FASEB J (2006) 0.98
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer. Breast Cancer Res Treat (2012) 0.98
Ultrastructural and chromosomal studies on manganese superoxide dismutase in malignant mesothelioma. Am J Respir Cell Mol Biol (2004) 0.98
Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis. Ann Thorac Surg (2003) 0.98
Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas. BMC Cancer (2011) 0.98
Type I and III collagen protein precursors and mRNA in the developing human lung. J Pathol (2004) 0.96
Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing. Matrix Biol (2008) 0.95
GATA-4 is an angiogenic survival factor of the infarcted heart. Circ Heart Fail (2010) 0.95
Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis. Eur J Cancer (2010) 0.94
Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression. BMC Cancer (2009) 0.94
Extracellular matrix proteins and myofibroblasts in granulomas of sarcoidosis, atypical mycobacteriosis, and tuberculosis of the lung. Hum Pathol (2006) 0.94
Divergent expression of claudin -1, -3, -4, -5 and -7 in developing human lung. Respir Res (2010) 0.94
Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma. PLoS One (2013) 0.94
Carbonic anhydrase IX in oligodendroglial brain tumors. BMC Cancer (2008) 0.93
Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression. BMC Cancer (2011) 0.93
Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients. Respir Res (2007) 0.93
Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients. Breast Cancer Res Treat (2011) 0.92
Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer. Hum Pathol (2011) 0.92
Modulation of DNA single-strand breaks by intracellular glutathione in human lung cells exposed to asbestos fibers. Mutat Res (2002) 0.92
Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival. J Neurooncol (2006) 0.92
High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma. APMIS (2003) 0.91
Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma. Oncol Rep (2009) 0.91
Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis. Atherosclerosis (2006) 0.91
Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival. Breast Cancer Res Treat (2013) 0.91
For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Arch (2015) 0.91
Expression of the thioredoxin system in interstitial lung disease. J Pathol (2003) 0.89
VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia. J Pathol (2002) 0.89
Tenascin-C and type I and III collagen expression in total Achilles tendon rupture. An immunohistochemical study. Histol Histopathol (2009) 0.89
Snail promotes an invasive phenotype in lung carcinoma. Respir Res (2012) 0.89
Progression of human aortic valve stenosis is associated with tenascin-C expression. J Am Coll Cardiol (2002) 0.88
Widening of the inferior alveolar canal: a case report with atypical lymphocytic infiltration of the nerve. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 0.87
Increasing oxidative damage and loss of mismatch repair enzymes during breast carcinogenesis. Eur J Cancer (2006) 0.87
Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer. Anticancer Res (2011) 0.87
VEGF and its receptors (flt-1 and KDR/flk-1) as prognostic indicators in endometrial carcinoma. Tumour Biol (2005) 0.87
Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas. Leuk Lymphoma (2011) 0.86
Antioxidant defense mechanisms in human neutrophils. Antioxid Redox Signal (2002) 0.86
Claudins 1, 4, 5, 7 and occludin in ameloblastomas and developing human teeth. J Oral Pathol Med (2007) 0.86
Sialometaplasia of the soft palate in a 2-year-old girl. J Mich Dent Assoc (2010) 0.85
Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma. Hum Pathol (2010) 0.85
Tight junction proteins in gallbladder epithelium: different expression in acute acalculous and calculous cholecystitis. J Histochem Cytochem (2007) 0.85
Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarction. Clin Transl Sci (2009) 0.84
Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer. BMC Cancer (2012) 0.84
Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma. Eur J Haematol (2002) 0.84
Impact of smoking on the expression of claudins in lung carcinoma. Eur J Cancer (2010) 0.84
Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins. J Clin Pathol (2010) 0.84
ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival. Cancer Epidemiol Biomarkers Prev (2010) 0.84
Nuclear factor-kappaB signaling contributes to severe, but not moderate, angiotensin II-induced left ventricular remodeling. J Hypertens (2007) 0.84
Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation. Hum Pathol (2008) 0.84
Acute edematous and necrotic pancreatitis in a porcine model. Scand J Gastroenterol (2008) 0.84
MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen. Acta Oncol (2014) 0.83
Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. APMIS (2004) 0.83
Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity. Respir Res (2008) 0.82
Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation. J Histochem Cytochem (2007) 0.82
Decreased expression of antioxidant enzymes is associated with aggressive features in ependymomas. J Neurooncol (2008) 0.82